The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VKTX FINANCIAL STATEMENTS

Viking Therapeutics Inc — balance sheet, income statement and cash flow trends

VKTXViking Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-208 K $ · -Infinity%Operating Income-560 M $ · -Infinity%Pre-tax Income-534.8 M $ · -Infinity%Net Income to Owners-534.8 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-208 K $—
Operating Income-560 M $—
EBITDA-534.4 M $—
Net Income to Owners-534.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets521.9 M
  • Equity408.3 M $78%
  • Current Liabilities109.7 M $21%
  • Long-term Liabilities3.9 M $1%

Key Figures

YoY change
Total Assets521.9 M $-37.0%
Total Liabilities113.6 M $+250.7%
Total Equity408.3 M $-48.7%
Cash & ST Investments501.7 M $-37.9%
Total Debt4.1 M $+365.4%
Net Debt-121.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-418.4 M $Operating399.3 M $Investing111.2 M $Financing92.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-418.4 M $—
Capital Expenditures0 $—
Free Cash Flow-418.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VKTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.